KV Pharma Can't Duck Securities Suit Over FDA Woes
A Missouri federal judge refused Tuesday to dismiss a proposed class action against KV Pharmaceutical Co., ruling that top officials likely knew that company reports failed to disclose U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article